Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease progression.

Scientists at St. Jude Children’s Research Hospital have used positron emission tomography (PET) with edaravone, a drug used ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Measuring blood levels of NfL, a biomarker of nerve damage, could help diagnose ALS and predict the risk of death for ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...

People with ALS have three times higher ... it can help in predicting prognosis, evaluating what stage of the disease people ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...

ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at ...